膈下逐瘀汤联合双氯芬酸钠栓治疗原发性气滞血瘀型痛经临床观察.docVIP

PAGE \* MERGEFORMAT 13 中文摘要 研究背景：痛经为妇科常见病之一，青年女性发病者较多，中医称其为“经行腹痛”。有原发性和继发性之分，症状严重的会对患者造成情绪、身心等方面的影响，导致患者在学习、工作和生活等方面表现不佳。原发性痛经是痛经其中的一种分类类型，不是因为组织器官发生病变而引起的痛经，这种类型的痛经占痛经患者的90%以上。膈下逐瘀汤（《医林改错》）和双氯芬酸钠栓（武汉同药药业）均为治疗原发性痛经的药物之一，但关于膈下逐瘀汤（《医林改错》）联合双氯芬酸钠栓（武汉同药药业）治疗原发性痛经的临床疗效还有待进一步的研究。目的：观察膈下逐瘀汤（《医林改错》）联合双氯芬酸钠栓（武汉同药药业）治疗原发性气滞血瘀型痛经的临床治疗效果。方法：将70例原发性痛经气滞血瘀型的患者随机分为两组。试验组35例，应用膈下逐瘀汤（《医林改错》）联合双氯芬酸钠栓（武汉同药药业，规格：50mg）治疗3个月经周期。对照组仅用同剂量的双氯芬酸钠栓（武汉同药药业，规格：50mg）治疗3个月经周期。两组分别在治疗前、治疗3个月经周期后分别进行评估主要症状、体征的缓解程度。试验结果：试验组治愈15例，显效11例，有效6例，总有效率91.4%；对照组治愈6例，显效9例，有效7例，总有效率62.9%，治疗3个月经周期后试验组的症状和体征的改善率明显高于对照组（P0.01），两组治疗3个月经周期后症状和体征的缓解程度均明显高于治疗前（P0.01）。结论：膈下逐瘀汤（《医林改错》）联合双氯芬酸钠栓（武汉同药药业）治疗原发性气滞血瘀型痛经能够明显改善患者症状和体征，且安全度良好。 关键词： 原发性痛经；膈下逐瘀汤；双氯芬酸钠栓；联合；疗效观察 Abstract Background: Dysmenorrhea?is one of?common gynecological diseases,?the incidence of?many?young women,?Chinese medicine?called by the line of abdominal pain.?There are?primary and secondary?branch,?serious impact?on the daily life?of?symptoms.?Primary dysmenorrhea?is a kind of?dysmenorrhea,?refers to the non?organic disease of?dysmenorrhea,?dysmenorrhea patients?accounted for?more than 90%?of all.?Gexiazhuyutang?(yilingaicuo)?and?diclofenac sodium suppository?(Wuhan?Tongyao pharmaceutical)?is?one of the?drugs?for the treatment of primary dysmenorrhea,?but?about?gexiazhuyutang?(yilingaicuo)?combined with diclofenac sodium?suppository?(Wu Hantong?Pharmaceutical?Medicine)?clinical curative effect of the treatment of?primary dysmenorrhea?are needed?further research. Objective：Observation of?gexiazhuyutang?(yilingaicuo)?combined with diclofenac sodium?suppository(Wuhan?with?medicine?medicine)?clinical curative effect of?the treatment of primarydysmenorrhea?of qi stagnation and blood stasis type. Methods: Patients were randomly divided into 70 cases?of primary dysmenorrhea?of qi stagnation and blood stasis type?into two groups.?35 cases of test group,?application of?gexiazhuyutang(yilingaicuo)?combined with diclofenac sodium?suppository?(Wuhan?with?pharm